Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent

Summary Background Data comparing tofacitinib and vedolizumab in ulcerative colitis (UC) are lacking. Aims To compare the effectiveness of tofacitinib and vedolizumab in patients with UC who had prior exposure to anti‐TNF therapy Methods In this multicentre study, we included consecutive patients wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary Pharmacology & Therapeutics (Suppl) 2023-03, Vol.57 (6), p.676-688
Hauptverfasser:	Buisson, Anthony, Nachury, Maria, Guilmoteau, Thomas, Altwegg, Romain, Treton, Xavier, Fumery, Mathurin, Serrero, Melanie, Leclerc, Eloïse, Caillo, Ludovic, Pereira, Bruno, Amiot, Aurélien, Bouguen, Guillaume
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antibodies, Monoclonal, Humanized - therapeutic use Colitis, Ulcerative - drug therapy Endoscopy Gastrointestinal Agents - therapeutic use Human health and pathology Humans Inflammatory bowel disease Life Sciences Patients Performance evaluation Remission Remission (Medicine) Remission Induction Steroids Treatment Outcome Tumor Necrosis Factor Inhibitors - therapeutic use Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!